Biodefense Market By Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear defense), Industry Trends, Estimation & Forecast, 2018-2025

Check Today's Best Price

$3500 Buy Now
Biodefense Market is expected to grow with a CAGR of xx% during the forecast period of 2017 to 2025.
  • Market Overview:

    Defensive measures taken against biological agents is termed as biodefense. It is undertaken to prevent and combat attacks by biological weapons such as disease-producing agents which include bacteria, viruses, rickettsiae, fungi, and toxins. The surging research and development investments in the field of biotechnology and increasing disease outbreaks is stimulating the growth of biodefense market. Advancements in genome editing has led to the transition of viruses into biological weapons used by various terrorist groups, which is a rising concern for the biodefense sector. Increasing biological weapon capabilities of certain countries arises a fear of biological attacks and bioterrorism which means defensive measures need to be planned accordingly. Moreover, efforts are being taken by Public Health Services and the government for developing tests and procedures to identify biothreat agents, which are propelling the market growth. According to the Arms Control Association, the Biological Weapons Convention (BWC) came into force in 1975, however, its implementation has been slower due to the lack of verification mechanisms.

    The partnerships and collaborations, as well as endeavors taken by the public and private sectors are expected to boost the market growth of biodefense. Various biosecurity threats from pandemics to laboratory accidents as well as militant groups are anticipated to create lucrative opportunities for the biodefense market to flourish in near future. For instance, Anthrax was deliberately spread through the US postal system in letters, which resulted in 5 deaths among 22 infected people according to the data cited by the Centers for Disease Control and Prevention.

    The report provides detailed qualitative and quantitative analysis of the biodefense market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segment namely product in each of the major regions.

    Biodefense Market Segmentation

    By Product

    • Anthrax
    • Smallpox
    • Botulism
    • Radiation/Nuclear defense
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. BIODEFENSE MARKET OVERVIEW
    2.1. BIODEFENSE MARKET INTRODUCTION
    2.2. GLOBAL BIODEFENSE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Biodefense Production (UNITS) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL BIODEFENSE MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Biodefense Capacity (UNITS) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL BIODEFENSE MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Biodefense Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL BIODEFENSE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Biodefense Consumption (UNITS) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL BIODEFENSE MARKET PRICE TREND, 2017-2025
    2.6.1. Global Biodefense Market Price Trend (Million USD) and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL BIODEFENSE MARKET BY PRODUCT, 2017-2025
    3.1. ANTHRAX
    3.2. SMALLPOX
    3.3. BOTULISM
    3.4. RADIATION/NUCLEAR DEFENSE
    3.5. OTHERS
    3.6. GLOBAL BIODEFENSE MARKET REVENUE BY PRODUCT, 2017-2025
    3.6.1. Global Biodefense Market Revenue (Million USD) and Share (%) By Product, 2017-2025
    3.6.2. Anthrax Market Revenue and Growth Rate, 2017-2025
    3.6.3. Smallpox Market Revenue and Growth Rate, 2017-2025
    3.6.4. Botulism Market Revenue and Growth Rate, 2017-2025
    3.6.5. Radiation/Nuclear defense Market Production and Growth Rate, 2017-2025
    3.6.6. Others Market Production and Growth Rate, 2017-2025
    3.7. GLOBAL BIODEFENSE MARKET PRODUCTION BY PRODUCT, 2017-2025
    3.7.1. Global Biodefense Market Production (Units) and Share (%) By Product, 2017-2025
    3.7.2. Anthrax Market Production and Growth Rate, 2017-2025
    3.7.3. Smallpox Market Production and Growth Rate, 2017-2025
    3.7.4. Botulism Market Production and Growth Rate, 2017-2025
    3.7.5. Radiation/Nuclear defense Market Production and Growth Rate, 2017-2025
    3.7.6. Others Market Production and Growth Rate, 2017-2025

    CHAPTER 4. GLOBAL BIODEFENSE MARKET BY REGION, 2017-2025
    4.1. NORTH AMERICA
    4.2. EUROPE
    4.3. ASIA-PACIFIC
    4.4. SOUTH AMERICA
    4.5. REST OF THE WORLD
    4.6. GLOBAL BIODEFENSE MARKET REVENUE BY REGION, 2017-2025
    4.6.1. Global Biodefense Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    4.6.2. North America Market Revenue and Growth Rate, 2017-2025
    4.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    4.6.4. Asia-Pacific Market Revenue and Growth Rate, 2017-2025
    4.6.5. South America Market Revenue and Growth Rate, 2017-2025
    4.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 5. GLOBAL BIODEFENSE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    5.1. GLOBAL BIODEFENSE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    5.1.1. Global Biodefense Market Production (Units) and Share (%) By Region, 2017-2025
    5.1.2. Global Biodefense Market Consumption (Units) and Share (%) By Region, 2017-2025
    5.1.3. North America Market Production and Consumption, 2017-2025
    5.1.4. Europe Market Production and Consumption, 2017-2025
    5.1.5. Asia-Pacific Market Production and Consumption, 2017-2025
    5.1.6. South America Market Production and Consumption, 2017-2025
    5.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 6. MARKET DETERMINANTS
    6.1. MARKET DRIVERS
    6.2. MARKET RESTRAINTS
    6.3. MARKET OPPORTUNITIES
    6.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 7. GLOBAL BIODEFENSE MARKET COMPETITION BY MANUFACTURERS
    7.1. GLOBAL BIODEFENSE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    7.1.1. Global Biodefense Production (UNITS) and Share (%) by Manufacturers (2017-2025)
    7.2. GLOBAL BIODEFENSE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    7.2.1. Global Biodefense Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    7.3. BIODEFENSE MARKET COMPETITIVE SITUATION AND TRENDS
    7.3.1. Biodefense Market Share (%) of Top 3 Manufacturers
    7.3.2. Biodefense Market Share (%) of Top 5 Manufacturers

    CHAPTER 8. GLOBAL BIODEFENSE MANUFACTURERS ANALYSIS
    8.1. XOMA CORPORATION
    8.1.1. Business Overview
    8.1.2. Company Basic Information
    8.1.3. Biodefense Product Details
    8.1.4. Xoma Corporation Biodefense Production and Revenue
    8.2. EMERGENT BIOSOLUTIONS
    8.2.1. Business Overview
    8.2.2. Company Basic Information
    8.2.3. Biodefense Product Details
    8.2.4. Emergent Biosolutions Biodefense Production and Revenue
    8.3. PHARMAATHENE
    8.3.1. Business Overview
    8.3.2. Company Basic Information
    8.3.3. Biodefense Product Details
    8.3.4. PharmaAthene Biodefense Production and Revenue
    8.4. SIGA TECHNOLOGIES
    8.4.1. Business Overview
    8.4.2. Company Basic Information
    8.4.3. Biodefense Product Details
    8.4.4. SIGA Technologies Biodefense Production and Revenue
    8.5. CLEVELAND BIOLABS
    8.5.1. Business Overview
    8.5.2. Company Basic Information
    8.5.3. Biodefense Product Details
    8.5.4. Cleveland BioLabs Biodefense Production and Revenue
    8.6. BAVARIAN-NORDIC
    8.6.1. Business Overview
    8.6.2. Company Basic Information
    8.6.3. Biodefense Product Details
    8.6.4. Bavarian-Nordic Biodefense Production and Revenue
    8.7. HYTEST
    8.7.1. Business Overview
    8.7.2. Company Basic Information
    8.7.3. Biodefense Product Details
    8.7.4. Hytest Biodefense Production and Revenue
    8.8. GSK
    8.8.1. Business Overview
    8.8.2. Company Basic Information
    8.8.3. Biodefense Product Details
    8.8.4. GSK Biodefense Production and Revenue
    8.9. SANOFI
    8.9.1. Business Overview
    8.9.2. Company Basic Information
    8.9.3. Biodefense Product Details
    8.9.4. Sanofi Biodefense Production and Revenue
    8.10. ARBUTUS BIOPHARMA
    8.10.1. Business Overview
    8.10.2. Company Basic Information
    8.10.3. Biodefense Product Details
    8.10.4. Arbutus Biopharma Biodefense Production and Revenue

    keyboard_arrow_up
  • • Xoma Corporation
    • Emergent Biosolutions
    • PharmaAthene
    • SIGA Technologies
    • Cleveland BioLabs
    • Bavarian-Nordic
    • Hytest
    • GSK
    • Sanofi
    • Arbutus Biopharma
    • DynPort Vaccine
    • Ichor Medical Systems
    • Aeolus Pharmaceuticals
    • Achaogen
    • Elusys Therapeutics
    • Dynavax Technologies
    • Soligenix
    • Alnylam Pharmaceuticals

     

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Biodefense Market in 2018 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2018 – 2025)?
• Which are the leading companies in the Biodefense Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS